Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates

Vertex Pharmaceuticals (VRTX) came out with a quarterly loss of $12.83 per share versus the Zacks Consensus Estimate of a loss of$11.50. This compares to earnings of $3.89 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.57$4.10 per share when it actually produced earnings of $4.76, delivering a surprise of 16.10%. Over the last four quarters, th ...